64-65 / 164
Single Laboratory Validation Report for Total Amino Acids by UHPLC-UV in Infant Formulas and Adult Nutritionals - APPENDICES
Jaudzems, Lahrichi, and Fuerer
–
January 2017
page 8/22
Appendix H
: recovery data obtained with the SPIFAN II SLV kit products, color-coded with respect to performance requirement values.
SPIFAN II SLV kit product
Analyte
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
av
His
98.4% 99.9% 98.6%
90.1%
100.1% 92.6% 99.6%
108.9%
94.8% 103.3% 95.1% 102.1% 96.0% 102.5% 97.9% 97.2% 97.7% 98.7% 97.5%
98.5%
Tau
100.3% 101.0% 99.1%
94.0%
96.0% 97.0% 97.0% 97.9% 96.2% 100.0% 95.9%
109.6%
99.7% 99.2% 98.2% 97.9% 99.2% 100.1% 99.4%
98.8%
Ser
109.5%
103.0% 96.6%
91.4% 79.8%
104.0%
93.2%
95.3% 97.5% 95.0%
93.2%
102.1%
93.0% 94.0%
96.8% 96.4%
91.8%
95.6% 99.1%
96.2%
Arg
96.5% 98.3% 101.4%
90.8%
92.4% 94.8%
91.9% 93.1%
93.2%
91.6% 93.8%
104.4%
90.3%
92.6% 94.5% 97.1% 95.7% 99.5% 95.9%
95.2%
Gly
100.2% 99.4% 100.4%
94.3%
98.4% 97.9% 97.5% 97.0% 97.1% 104.4% 97.5% 107.2% 106.2% 102.3% 97.0% 98.2% 101.2% 99.4% 98.6%
99.7%
Asp
112.7% 110.5%
102.8% 101.1%
108.0% 105.2%
104.9%
108.5% 114.1% 107.4%
104.1%
112.1% 108.5% 108.9% 106.6%
103.6%
105.0%
102.3%
105.5%
106.9%
Glu
106.9%
103.5%
105.5% 94.2%
103.6% 103.4% 98.6% 102.1%
110.4%
103.6% 99.6%
109.7%
103.3% 103.8% 101.1% 100.0% 101.3% 98.7% 98.4%
102.5%
Thr
100.0% 99.2% 98.6%
92.0% 90.5%
99.6%
94.8%
95.7% 97.2% 97.2%
94.8%
104.6% 96.8% 97.2% 96.6% 96.7% 96.1% 97.2% 97.7%
97.0%
Ala
102.2% 102.2% 101.7% 95.7% 99.9% 99.5% 98.0% 101.1% 104.2% 101.5% 98.2%
107.6%
102.1% 101.7% 99.9% 98.9% 100.1% 99.7% 99.3%
100.7%
Pro
101.0% 100.5% 103.5%
93.7%
97.4% 100.2% 95.5% 99.1% 101.4% 99.1%
94.3% 106.3%
98.8% 99.5% 98.4% 97.5% 99.0% 99.3% 97.0%
99.0%
Lys
107.7% 106.2% 106.6%
98.9% 100.5% 100.6% 97.3%
105.8% 112.9%
100.5% 97.1% 104.3% 102.5% 101.9% 102.5% 102.1% 104.3% 104.1% 99.6%
102.9%
Tyr
99.9% 99.9% 98.4%
93.9% 92.8%
96.1% 92.6% 94.1% 95.7% 97.9%
93.5%
102.2% 95.7% 97.3% 96.8% 97.2% 96.8% 99.1% 96.9%
96.7%
xCys
102.0% 102.6% 103.3% 94.0% 96.4% 99.4% 96.6% 99.8% 99.7% 101.3% 102.2% 100.6% 98.7% 100.4% 100.8% 99.9% 101.8% 96.1% 97.2%
99.6%
Met
88.7% 90.1% 94.6% 90.2% 89.6%
95.4%
89.8% 88.2% 90.2%
95.8%
90.2%
102.5% 93.9% 94.9% 92.7% 93.6% 92.7%
93.6% 90.8%
92.5%
Val
94.0%
101.2% 100.5%
85.4%
101.5%
91.6% 94.3%
98.4% 100.0% 98.3% 95.3%
107.9%
100.5% 99.3% 98.1% 97.3% 99.8% 102.8%
93.4%
97.9%
Ile
94.2%
101.0% 99.7%
87.0%
101.3%
89.8% 93.8%
97.7% 98.7% 101.2% 96.1%
107.6%
99.9% 99.6% 97.6% 97.5% 99.5% 102.1%
94.8%
97.9%
Leu
100.2% 101.5% 102.2%
91.4%
98.9% 96.8% 95.8% 98.8% 102.0% 99.6% 96.4%
107.9%
101.5% 100.1% 99.0% 98.3% 99.9% 101.6% 95.7%
99.3%
Phe
99.9% 100.8% 100.3%
93.0%
98.4% 96.8% 96.8% 95.9% 96.4% 100.2% 96.4%
108.2%
102.1% 100.0% 98.8% 98.2% 99.4% 100.8% 97.5%
98.9%
Recovery data were obtained with robust statistics.
For each analyte/matrix pair, the recovery was compared with the corresponding performance requirement. 77% of the values are within the
requirements (green) and 23% outside (red). The last column represents the averaged values for each analyte, and is color-coded for clarity
from lowest (red) to highest (green).
AMINO-01 (FEBRUARY 2017) - APPENDICES
FOR ERP USE ONLY
DO NOT DISTRIBUTE